Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
News|Articles|February 16, 2024

Butterfly Network Launches New Handheld Ultrasound System

Author(s)Jeff Hall

Recently cleared by the FDA, the iQ3 point-of-care ultrasound system reportedly offers new advances in 3D imaging capabilities.

Offering a combination of enhanced image processing, artificial intelligence (AI) tools and improved 3D imaging, the Butterfly Network has unveiled the iQ3TM handheld ultrasound.

In addition to a “no focus” rubber lens that facilitates improved observation of small anatomical structures, the iQ3 point-of-care device also features 3D imaging advances with iQ Slice and iQ Fan.

Butterfly Network said the iQ Slice technology features automated steering of the beam for optimal organ scanning and can capture 46 ultrasound slices simultaneously across a wide angle. With real-time virtual fanning, the iQ Fan provides clinicians with smoother visualization of A-lines and other lung conditions, according to Butterfly Network.

The company added that these 3D imaging advances with the iQ3 device are combined with existing AI tools, six imaging modes and over 20 anatomical presets in Butterfly Network ultrasound devices.

“The introduction of Butterfly iQ3 includes a focus on higher precision capabilities for cardiovascular point-of-care ultrasound applications to inform complex decisions,” noted Partho Sengupta, M.D., the chief of cardiology at Rutgers Robert Wood Johnson Medical School. “In my early experience, I found that the enhancements in visualization technology and artificial intelligence, as well as image quality will greatly assist health care professionals in our efforts to continually improve outcomes for our patients.”


Related to this article

Emerging Research Insights and New Advances in Neuroradiology
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Current Perspectives on Integrating AI into Radiology
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.